Diabetes is rising at an alarming rate among young adults in India, driven by genetic predisposition, unhealthy lifestyles, ...

One of the oldest challenges in oncology is creating a drug that kills cancer cells while sparing healthy ones. Peptides are ...

The crypto market is experiencing a new wave of AI-backed projects taking the lead, and among them, Ozak AI (OZAK) has ...

Great Lakes Dredge & Dock boasts industry-leading, rising ROE, driven by productivity gains, strong backlog, and effective ...

Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I ...

Debiopharm is advancing its ADC platform with a focus on proprietary bispecific ADCs and innovative payloads. By leveraging its proven drug development expertise, the company aims to accelerate ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Q3 Revenue up 20% Year-Over-Year to $162.5 Million Q3 Net Income up 139% Year-Over-Year to $5.5 Million Q3 Gross Profit up 40% Year-Over-Year to ...

Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue increased by 85%, to $237 million in the first nine mon ...

The pen trembles slightly in his hand, hovering over the page. Outside, the sunlight fades behind the trees around his small ...